Jeev Bramha Seva Medical & Research Institute Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-01-2025
- Paid Up Capital ₹ 2.00 M
as on 11-01-2025
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.35 M
as on 11-01-2025
- Revenue 47.48%
(FY 2021)
- Profit 11.60%
(FY 2021)
- Ebitda -3.21%
(FY 2021)
- Net Worth 15.34%
(FY 2021)
- Total Assets 3.95%
(FY 2021)
About Jeev Bramha Seva Medical & Research Institute
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹9.35 M.
Uttamrao Sawant, Koushalya Sawant, Shubhada Sawant, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110PN2010PTC135941
- Company No.
135941
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeev Bramha Seva Medical & Research Institute?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttamrao Sawant  | Director | 29-Mar-2010 | Current |
| Koushalya Sawant | Director | 29-Mar-2010 | Current |
| Shubhada Sawant | Director | 29-Mar-2010 | Current |
| Nitin Sawant | Director | 29-Mar-2010 | Current |
Financial Performance of Jeev Bramha Seva Medical & Research Institute.
Jeev Bramha Seva Medical & Research Institute Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 47.48% increase. The company also saw a substantial improvement in profitability, with a 11.6% increase in profit. The company's net worth Soared by an impressive increase of 15.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeev Bramha Seva Medical & Research Institute?
In 2021, Jeev Bramha Seva Medical & Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Mar 2017 | ₹9.35 M | Open |
How Many Employees Work at Jeev Bramha Seva Medical & Research Institute?
Jeev Bramha Seva Medical & Research Institute has a workforce of 56 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeev Bramha Seva Medical & Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeev Bramha Seva Medical & Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
